First Narcolepsy Drug Targets Root Cause, Not Symptoms

The FDA just approved Orzeyful, the first medication that treats the underlying cause of narcolepsy type 1 instead of just masking symptoms.

For 120,000 Americans living with extreme daytime sleepiness and sudden muscle weakness, this breakthrough could transform daily life.